Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
pembrolizumab
×
Plasma cell
×
Clear all
Filters
3
NCT02362035
2025-12-11
KEYNOTE145
Acerta Pharma BV
Phase 1/2
Completed
161 enrolled
29 charts
NCT01953692
2021-08-04
MK-3475-013
Merck Sharp & Dohme LLC
Phase 1
Completed
197 enrolled
52 charts